Rankings
▼
Calendar
VCEL FY 2014 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
FY 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$29M
+151457.9% YoY
Gross Profit
$12M
39.9% margin
Operating Income
-$24M
-81.7% margin
Net Income
-$20M
-69.2% margin
EPS (Diluted)
$-1.71
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$26M
Stock-Based Comp.
$839,000
Balance Sheet
Total Assets
$48M
Total Liabilities
$12M
Stockholders' Equity
$36M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$29M
$19,000
+151457.9%
Gross Profit
$12M
$15,000
+76586.7%
Operating Income
-$24M
-$21M
-12.3%
Net Income
-$20M
-$16M
-27.5%
← FY 2013
All Quarters
FY 2015 →